Skip to main navigation
Skip to search
Skip to main content
University of Eastern Piedmont Home
Italiano
English
Home
Profiles
Research units
Equipment
Projects
Research output
Search by expertise, name or affiliation
NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy
Matthias Pinter
,
David J. Pinato
, Pierluigi Ramadori
, Mathias Heikenwalder
Department of Translational Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Immunology
100%
Hepatocellular Carcinoma
100%
Immunotherapy
100%
Nonalcoholic Fatty Liver
100%
Diseases
16%
Immunocompetent Cell
8%
Clinical Finding
8%
Carcinogenesis
8%
Fibrosis
8%
Liver Cancer
8%
Liver Cirrhosis
8%
Cancer Risk
8%
Disease Management
8%
Keyphrases
Immunology
100%
Hepatocellular Carcinoma
100%
Nonalcoholic Steatohepatitis
100%
Clinical Translation
9%
Cirrhosis
9%
Oncogenesis
9%
Viral
9%
Fibrosis
9%
Patient Survival
9%
Adaptive Immune Response
9%
Cancer Risk
9%
Non-alcoholic Fatty Liver Disease (NAFLD)
9%
Liver Cancer
9%
Potential Therapeutics
9%
Disease Management
9%
Immunobiology
9%
Disease Entity
9%
Innate Immune Cells
9%
Chemotherapy Resistance
9%
Conclusive Evidence
9%
Pro-tumorigenic
9%
Therapeutic Vulnerabilities
9%
Immunotherapy Efficacy
9%
Immunology and Microbiology
Immunology
100%
Immunotherapy
100%
Steatohepatitis
100%
Immunocompetent Cell
9%
Preclinical Study
9%